Location: Switzerland, or remote with regular professional travels in EU, US and LMICS Contract: fixed term (18 months) employment or consultancy with a possibility to extend
The Medicines Patent Pool (MPP) is a dynamic and innovative public health organization dedicated to improving global health outcomes by accelerating access to life-saving medicines and fostering their sustainable and affordable production. Through licensing and technology transfer, MPP works collaboratively with stakeholders across the pharmaceutical landscape, including patent holders, manufacturers, and global health organizations, to ensure medicines reach those who need them most.
At the heart of our mission is a commitment to sustainability, affordability, and regional manufacturing to empower low- and middle-income countries reached by enabling the production of high-quality medicines locally. In addition, MPP supports pandemic preparedness and enhances inter-pandemic resilience, ensuring that health systems are equipped to respond effectively to both current and future global health challenges.
Joining MPP means becoming part of a team that is driving innovation in public health, building sustainable manufacturing ecosystems, and transforming lives through equitable access to essential medicines.
For more information, please see our website, https://medicinespatentpool.org/
Since 2021, MPP has co-led the mRNA Technology Transfer Programme with the World Health Organization (WHO), with the aim of supporting the development and dissemination of mRNA technology to enhance regional manufacturing capacity. This initiative has established a robust mRNA technology platform, which is being shared with 15 manufacturing partners in low- and middle-income countries through a multilateral technology transfer model. These efforts are designed to ensure equitable access to mRNA vaccines and therapeutics while strengthening local production capabilities.
The programme has already achieved important milestones, including the successful establishment of the mRNA platform and the readiness of manufacturing partners to adopt the technology. Looking ahead, 2025 and 2026 will focus on the implementation of the technology platform at the receiving manufacturing partners and product development activities, to enable the manufacturing partners to produce mRNA-based vaccines and therapeutics for inter-pandemic use and beyond.
While mRNA technology has been a major focus, MPP is also actively exploring additional technology platforms to address the broader needs of its manufacturing partners. These efforts reflect MPP’s commitment to supporting sustainable manufacturing ecosystems that can respond effectively to global health challenges.
Building on this effort, MPP is seeking a Technology Transfer Expert to join its team and play a key role in advancing the development, transfer, and implementation of innovative health technologies with manufacturing partners worldwide.
Main Duties/Responsibilities
Reporting to the Director of Technology Transfer, the main activities of the Technology Transfer Expert will be to support the Medicines Patent Pool and its partners by providing expert technical support to the Medicines Patent Pool’s work related to technology transfer, enhancement of biologics local production capacity in LMICs, the WHO initiatives on local production and in any other initiative concerning production partnerships. The Technology Transfer Expert will:
Requirements
Essential
Desirable:
Personal Qualities
The richness of MPP lies in its staff: a small, dynamic and multicultural team. The values of Respect, Courage, Generosity and Commitment are essential for a successful outcome.
To thrive in MPP’s dynamic environment and meaningfully contribute to our mission, the Technology Transfer will need to demonstrate the following personal qualities:
MPP respects all individuals regardless of race, gender, ethnicity, sexual orientation, religion, HIV status or disability. All qualified applications are welcome.
If you recognise yourself in this description and wish to join our team please send a cover letter and C.V. to recruitment@medicinespatentpool.org including “Technology Transfer Expert” as reference in the subject line by 19 February 2025.
Département communication, presse et médias
Le Medicines Patent Pool (MPP) est une organisation de santé publique soutenue par les Nations Unies, dont la mission est d’améliorer l’accès à des médicaments essentiels dans les pays à revenu faible et intermédiaire, et de faciliter la mise au point de tels médicaments. Au travers de son modèle économique innovant, le MPP collabore avec la société civile, les gouvernements, des organisations internationales, l’industrie, des groupes de patients et d’autres acteurs afin d’établir des priorités, de délivrer des licences sur les médicaments indispensables et de centraliser les actifs de propriété intellectuelle pour faciliter la fabrication de médicaments génériques et l’élaboration de nouvelles formulations.
À ce jour, le MPP a signé des accords avec 22 titulaires de brevets pour 13 antirétroviraux contre le VIH, une plateforme technologique sur le VIH, trois antiviraux à action directe contre l’hépatite C, un traitement contre la tuberculose, un traitement contre le cancer, quatre technologies à action prolongée, un traitement de l’hémorragie du post-partum, trois traitements antiviraux oraux contre la COVID-19 et 16 technologies liées à la COVID-19.
MPP a été fondé par Unitaid, qui continue d’être le principal bailleur de fonds de MPP. Le travail de MPP sur l’accès aux médicaments essentiels est également financé par l’Agence suisse pour le développement et la coopération (SDC), le gouvernement du Canada, l’Organisation mondiale de la propriété intellectuelle (OMPI) et le gouvernement de la Flandre. Les activités de MPP dans le cadre de la COVID-19 sont entreprises avec le soutien financier du gouvernement japonais, du ministère français de l’Europe et des Affaires étrangères, de l’Agence allemande de coopération internationale et de la SDC.